Skip to main content

Table 1 Clinical and biochemical characteristics of the study participants

From: Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure

  HF patients with low LVEF HF patients with normal LVEF Control subjects p value
(n = 25) (n = 23) (n = 21)
Clinical profile     
 Male sex, n (%) 21 (84 %) 22 (96 %) 17 (81 %) 0.31
 Age (years) 56.0 ± 7.7 56.1 ± 8.7 58.9 ± 7.2 0.39
 Height (cm) 166.8 ± 8.6 165.8 ± 7.0 164.3 ± 5.0 0.48
 Weight (kg) 71.6 ± 15.9 72.5 ± 12.0 70.9 ± 10.4 0.92
 BMI (kg/m2) 25.5 ± 4.3 26.4 ± 4.1 26.3 ± 4.0 0.75
 SBP (mmHg) 127.0 ± 25.4* 134.0 ± 18.6 145.7 ± 7.0 0.03
 DBP (mmHg) 74.3 ± 10.8* 73.7 ± 9.4 * 83.7 ± 12.5 0.01
Biochemical profile    
 Triglyceride (mg/dL) 150.4 ± 60.3 168.5 ± 98.2 179.1 ± 4.8 0.65
 Total cholesterol (mg/dL) 189.8 ± 34.3 180.6 ± 31.7 178.4 ± 0.0 0.70
 LDL (mg/dL) 115.5 ± 35 108.2 ± 29.7 95.1 ± 50.2 0.39
 VLDL (mg/dL) 29.7 ± 12.6 33.8 ± 19.6 31.3 ± 23.3 0.74
 HDL (mg/dL) 45.4 ± 10.1 38.6 ± 8.4 45.9 ± 25.6 0.14
 T-cho/HDL 4.4 ± 1.3 4.9 ± 1.3 * 3.2 ± 2.0 0.04
 LDL/HDL 2.7 ± 1.1 2.9 ± 1.1 3.3 ± 3.7 0.74
 Non-HDL (mg/dL) 144.4 ± 37.3 142.0 ± 30.3 116.2 ± 3.9 0.27
 Fasting glucose (mg/dL) 121.2 ± 38.1 113.4 ± 77.1 93 ± 41.3 0.52
 HbA1c (mg/dL) 6.4 ± 1.2 6.5 ± 1.5 * 4.1 ± 2.7 0.03
  1. Data are expressed as means ± standard deviations. P values are calculated from one-way analysis of variance
  2. Abbreviations: HF, heart failure; LVEF left ventricular ejection fraction, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, DM diabetes mellitus, MI prior myocardial infarction, DCM dilated cardiomyopathy, HDL high-density lipoprotein cholesterol, T-cho total cholesterol VLDL very low-density lipoprotein cholesterol, LVL low-density lipoprotein cholesterol, HbA1c glycated hemoglobin
  3. * p < 0.05 vs. controls